In Brief: Sulzermedica
This article was originally published in The Gray Sheet
Executive Summary
Sulzermedica: Expands its cardiovascular offerings through the acquisition of Germany-based Osypka GmbH and Palm Harbor, Florida-based Oscor Medical, which had combined 1995 sales of over $20 mil. In the U.S., Oscor primarily markets pacemaker leads, including a line manufactured by Osypka. Osypka's product line in Europe includes a radiofrequency ablation system, external and implantable pacemakers and an angioplasty balloon catheter, all of which Sulzermedica plans to evaluate for potential marketing in the U.S. Terms of the deal are expected to be disclosed during the week of Jan. 22...